Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 22/08/20001 min de lecture
Ophthalmic and Topical Dosage Form New Animal Drugs; 2-Mercaptobenzothiazole Solution
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Combe, Inc. The supplemental NADA provides for the topical use of 2-mercaptobenzothiazole solution as an aid in the treatment of certain common skin inflammations in dogs.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →